Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAART study in ART-naive adults with HIV infection
PACTR201312000661337Completed
- Sponsor
- Ahmadu Bello University Teaching Hospital
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of tenofovir, lamivudine, zidovudine, nevirapine and efavirenz in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Ahmadu Bello University Teaching Hospital. Primary endpoint: Virologic response at 6 months. Started Jun 2012; status: completed.
02
Drugs
tenofovirlamivudinezidovudinenevirapineefavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR201312000661337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201312000661337.